- Home
- STK
as 11-21-2024 10:39am EST
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 553.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 38.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $24.95 - $34.31 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Columbia Seligman Premium Technology Growth Fund Inc News
STK Breaking Stock News: Dive into STK Ticker-Specific Updates for Smart Investing
Business Wire
13 days ago
Columbia Seligman Premium Technology Growth Fund Announces a Fourth Quarter Distribution: 9.25% Annual Rate for IPO Investors
Business Wire
3 months ago
Columbia Seligman Premium Technology Growth Fund Announces a Third Quarter Distribution: 9.25% Annual Rate for IPO Investors
Business Wire
5 months ago
Columbia Seligman Premium Technology Growth Fund, Inc. Holds 14th Annual Meeting of Stockholders
Yahoo Finance Video
5 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
5 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
5 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
5 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
GlobeNewswire
5 months ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Compare STK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STK Columbia Seligman Premium Technology Growth Fund Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.